| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $165.8M | +11.6% |
| Cost of Revenue | $51.7M | +8.0% |
| R&D Expense | $50.7M | -9.6% |
| SG&A Expense | $62.2M | +37.2% |
| Pre-tax Income | $4.9M | +936.0% |
| Income Tax | $1.8M | -54.8% |
| Net Income | $3.1M | +190.6% |
| EPS (Basic) | $0.08 | +188.9% |
| EPS (Diluted) | $0.08 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.0M | -17.3% |
| Short-term Investments | $36.5M | +86.9% |
| Accounts Receivable | $44.9M | +6.5% |
| Current Assets | $197.8M | +2.3% |
| Total Assets | $290.1M | +4.1% |
| Current Liabilities | $50.8M | -12.6% |
| Total Liabilities | $61.2M | -10.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $14.6M | -54.8% |
| Capital Expenditures | $11.2M | +33.6% |
| Investing Cash Flow | -$29.0M | -134.3% |
| Financing Cash Flow | -$5.9M | +75.8% |
| Free Cash Flow | $3.4M | -85.9% |
| +188.9% |
| Stockholders' Equity |
| $228.9M |
| +9.0% |